Selumetinib in combination with dexamethasone for the treatment of relapsed/refractory RAS-pathway mutated paediatric and adult acute lymphoblastic leukaemia (SeluDex): study protocol for an international, parallel-group, dose-finding with expansion phase I/II trial

T. Menne, D. Slade, J. Savage, Sarah Johnson, Julie A E Irving, P. R. Kearns, Ruth Plummer, Geoff Shenton, G. J. Veal, Britta Vormoor, Josef Vormoor, Lucinda Billingham

Research output: Working paper/Preprint › Preprint

Fingerprint

Dive into the research topics of 'Selumetinib in combination with dexamethasone for the treatment of relapsed/refractory RAS-pathway mutated paediatric and adult acute lymphoblastic leukaemia (SeluDex): study protocol for an international, parallel-group, dose-finding with expansion phase I/II trial'. Together they form a unique fingerprint.

Medicine & Life Sciences